BioAdaptives Launches MyndMed Cognitive Supplement Following Positive Testing Results
October 7th, 2025 4:00 PM
By: Newsworthy Staff
BioAdaptives, Inc. has commercially launched MyndMed, a cognitive-support dietary supplement designed to enhance memory and focus, representing an important advancement in natural brain health solutions with strong early market demand.

BioAdaptives, Inc. (OTCMKTS: BDPT) has announced the commercial launch of MyndMed, a next-generation dietary supplement specifically formulated to enhance memory, focus, and overall brain performance. The product launch follows extensive testing that generated highly positive user feedback, prompting the company to scale production and expand distribution to meet anticipated high demand beginning in November. This strategic move positions BioAdaptives to capitalize on growing consumer interest in cognitive enhancement solutions.
The MyndMed formulation is designed to support cognitive function across multiple timeframes, addressing short-, mid-, and long-term brain health pathways. The company describes the product as providing Mental Armor for Modern Minds through clinically studied ingredients that promote alertness, neuroplasticity, and cellular energy balance. This comprehensive approach to cognitive support represents a significant development in the dietary supplement market, particularly as consumers increasingly seek natural alternatives for maintaining brain health and performance.
Manufacturing quality and product safety are central to the MyndMed launch strategy. The supplement is produced in cGMP-certified facilities within the United States and undergoes rigorous third-party testing to ensure purity and quality standards. This manufacturing approach provides consumers with confidence in the product's safety profile while supporting the company's commitment to delivering science-based health solutions. The nationwide availability of MyndMed through www.MyndMed.com ensures broad consumer access to this cognitive support formulation.
The successful testing phase and strong early demand indicate significant market potential for MyndMed within the rapidly growing cognitive health supplement sector. BioAdaptives' development of this product aligns with increasing consumer awareness about brain health maintenance and cognitive performance optimization. The company's focus on leveraging cutting-edge research in natural health formulations positions MyndMed as a competitive offering in the dietary supplement market. Additional information about the company and its products can be found at www.bioadaptives.com, while the complete press release details are available at https://ibn.fm/2isuA.
Source Statement
This news article relied primarily on a press release disributed by InvestorBrandNetwork (IBN). You can read the source press release here,
